Cycuria to Present at the Startup Spotlight at BIO-Europe Spring
Cycuria has been selected to present at the Startup Spotlight Stage during the upcoming BIO-Europe Spring partnering conference! Our presentation will showcase Cycuria’s pioneering approach to decoupling toxicity from long-lasting efficacy in the treatment of hematological cancers through our first-in-class, protein-based targeted therapy. We will share our progress to date and our vision for the […]
Meet Cycuria at ASH Annual Meeting 2024 in San Diego
Cycuria will be attending the upcoming American Society of Hematology (ASH) Annual Meeting in San Diego from December 7- December 10. We look forward to exciting and stimulating discussions with scientists, clinicians and industry professionals who are shaping the future of cancer care. See you there!
Cycuria to Present at the Upcoming BIO-Europe Partnering Conference in Stockholm
Cycuria will be participating at the upcoming BIO-Europe partnering event in Stockholm, Sweden from 4th-6th Nov. Reach out to schedule one-on-one meeting with our CEO through the partnering platform.
Cycuria to Present at the Upcoming Biotech Summit Austria
Date: 9-11th October, 2024 Join our CEO as he presents the Cycuria story at the upcoming Biotech Summit Austria in Innsbruck.